SI
Sintetica Ltd
Has won 7 UK public-sector contracts worth £944k across 5 buyers, primarily NHS England and NHS Improvement.
Active contracts
6
no new awards in 30d
Contracted (12m)
—
no data
Public buyers
5
stable this month
Top buyer share
100%
NHS England and NHS Improvement
Buyer concentration
Each block sized by share of total award value. A dominant block signals dependency on one buyer.
Severe concentration. Top buyer alone = 100% of revenue.
NHS England and NHS Improvement
£944k
100%NHS England
—
0%Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts)
—
0%The NHS Commissioning Board (operating under the name of NHS England)
—
0%The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
—
0%Contracts won · 7 total · 6 active · 1 expired
Every contract award published under the Procurement Act.
| Title | Buyer | Award type | Value | Awarded | Status |
|---|---|---|---|---|---|
| NHS National Pharmaceuticals Transition 2022_1 | NHS England and NHS Improvement | Framework call off | £944k ceiling · ~£22k share (÷42) | 19 Jul 2022 | expired |
| NHS National Generic Pharmaceuticals Wave 14b | NHS England | Direct contract | — | — | active |
| NHS National Generic Pharmaceuticals Wave 14b | NHS England | Direct contract | — | — | active |
| NHS National Pharmaceuticals Transition 2022_1 | NHS England | Direct contract | — | — | active |
| Generic Drugs - Injections/Infusions | Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts) | Direct contract | — | — | active |
| NHS National Generic Pharmaceuticals Wave 13 | The NHS Commissioning Board (operating under the name of NHS England) | Direct contract | — | — | active |
| Cardiovascular & Respiratory Medicines | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | Shared contract | — lot total · 38 suppliers | — | active |